Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia Patients

Chemotherapy for acute lymphoblastic leukemia (ALL) patients is complex and intense, resulting in a high readmission rate. We aimed to identify the incidence, causes, and risk factors of readmission following inpatient chemotherapy among ALL patients, using 2016 National Readmission Database. We app...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Phuong T., Slayton, William B., Dalal, Mansi, Brown, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720128/
https://www.ncbi.nlm.nih.gov/pubmed/33066571
http://dx.doi.org/10.3390/healthcare8040401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720128/
https://www.ncbi.nlm.nih.gov/pubmed/33066571
http://dx.doi.org/10.3390/healthcare8040401

Ejemplares similares